Dept of Molecular Pathology, 9500 Euclid Ave, LL2-2, Cleveland, OH 44195;
Am J Clin Pathol. 2014 May;141(5):718-23. doi: 10.1309/AJCPOWHOIZBZ3FRW.
Duplicate laboratory tests that are unwarranted increase unnecessary phlebotomy, which contributes to iatrogenic anemia, decreased patient satisfaction, and increased health care costs.
We employed a clinical decision support tool (CDST) to block unnecessary duplicate test orders during the computerized physician order entry (CPOE) process. We assessed laboratory cost savings after 2 years and searched for untoward patient events associated with this intervention.
This CDST blocked 11,790 unnecessary duplicate test orders in these 2 years, which resulted in a cost savings of $183,586. There were no untoward effects reported associated with this intervention.
The movement to CPOE affords real-time interaction between the laboratory and the physician through CDSTs that signal duplicate orders. These interactions save health care dollars and should also increase patient satisfaction and well-being.
不必要的重复实验室检测会增加不必要的采血，导致医源性贫血、降低患者满意度和增加医疗保健成本。
我们在计算机化医嘱录入（CPOE）过程中使用临床决策支持工具（CDST）来阻止不必要的重复检测医嘱。我们在 2 年后评估了实验室成本节约情况，并寻找与该干预措施相关的不良患者事件。
在这 2 年中，该 CDST 阻止了 11790 次不必要的重复检测医嘱，节省了 183586 美元。没有报告与该干预措施相关的不良影响。
向 CPOE 的转变通过 CDST 为实验室和医生提供了实时交互，这些交互信号提示重复检测。这些交互可以节省医疗保健费用，还应该提高患者的满意度和幸福感。
